ATGAM General Investigation

Active, not recruitingOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

January 22, 2027

Study Completion Date

January 22, 2027

Conditions
Aplastic Anemia
Interventions
DRUG

Anti-human thymocyte immunoglobulin, equine

Usually, 40 mg of anti-human thymocyte immunoglobulin, equine per kilogram of body weight should be slowly administered by intravenous drip infusion once daily. The duration of treatment should be 4 days.

Trial Locations (1)

Unknown

Pfizer, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY